valerylsalicylate has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dalain, S; Alvarez, D; Candelario-Jalil, E; García-Cabrera, M; González-Falcón, A; León, OS; Martínez, G; Springer, JE | 1 |
1 other study(ies) available for valerylsalicylate and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.
Topics: Animals; Antioxidants; Biomarkers; Cell Count; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Disease Progression; Gerbillinae; Glutathione; Hippocampus; Ischemic Attack, Transient; Isoenzymes; Lactones; Lipid Peroxidation; Male; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Salicylates; Sulfones | 2003 |